SR. NO | TEST | TEST COMPONENTS | Method | Specimen/Transport | TAT | Clinical Applications |
---|---|---|---|---|---|---|
1 | Troponin I | CLIA | Serum | 2Hrs | Myocardial infaraction | |
2 | CK-MB | CLIA | Serum | 4Hrs | Myocardial infaraction | |
3 | Homocysteine | CLIA | Serum | 4Hrs | Cardiac risk predictor | |
4 | Myoglobin | CLIA | Serum | 4Hrs | Myocardial infarction, myopathies. | |
5 | Fibrinogen degradation product | Latex agglutination | Citrate Plasma | 4Hrs | DIC, DVT, PE | |
6 | D-Dimer | CLIA | Citrate Plasma | 4Hrs | DIC, DVT, PE | |
7 | PF4 Antibody | Gel Card | Serum | 4Hrs | Heparin-induced thrombocytopenia (HIT-II) | |
8 | NT proBNP | CLIA | EDTA | 4Hrs | Acute congestive heart failure | |
9 | Lipid Index | Lipid profile + Lipoprotein A, Apolipoprotein A1+B | EZYMATIC + IMMUNOTURBIDIMETRY | Serum | 4Hrs | Myocardial infarction |
10 | HsCRP | Nephelometry | Serum | 4Hrs | Myocardial infarction |